Press Releases and News
- Establishes ResMed as a leader in COPD patient management, across all stages of the disease - Propeller Health will operate as a standalone business, maintaining its COPD...
Research from UW-Madison, UC Berkeley and Propeller Health suggests that reducing fine particulate matter concentration would generate significant annual cost savings in...
Company's 16th peer-reviewed study indicates that inhaler puffs, not patient-reported occasions, are the most objective way to measure rescue inhaler usage MADISON, Wis.,...
Propeller Health’s digital medicines allow Anthem Blue Cross and Blue Shield consumers to better manage COPD symptoms The digital medicine consists of small sensors that...
MADISON, Wis., June 11, 2018 - Propeller Health, a leading digital therapeutics company, announced a strategic investment of an undisclosed amount from McKesson Ventures,...
Company’s 15th peer-reviewed study adds valuable insights into how patients experience and perceive digital health interventions for asthma MADISON, Wis., June...
Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes CRYSTAL...
Financing led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma Ventures, 3M Ventures and SR One MADISON, Wis., May...
MADISON, Wis., April 2, 2018 - Today Propeller Health and peer-reviewed healthcare journal, Health Affairs, published results from a cross-sector partnership...
My Propeller
Propeller Logo
